Patients receive individually prepared injections with the same active ingredient at a fraction of the cost, making treatment financially sustainable long-term
- -:
TB-500, a synthetic fragment corresponding to the active region of the endogenous peptide Thymosin Beta-4, drives the cellular migration phase of repair by sequestering G-actin, promoting cell motility, and mobilising stem and progenitor cells to sites of tissue disruption
"Collaborating with esteemed health experts Dr
Complementary solutions Aligned to scale with your pharmacy benefit needs Our pharmacy benefit solutions are aligned to your priorities, not the other way around
The tool allows patients to report the drug, dose and pharmacy where they find a supply of GLP-1 medications, and to report shortages that can be automatically sent to the Food and Drug Administration (FDA)